Heart Failure (HF) is one of the main causes of mortality and morbidity globally, affecting around 26M people globally. Lung fluid congestion is one of the main clinical conditions related to HF and represents the leading cause of hospitalizations (90%) and death in HF patients. One-year mortality is estimated at 16,5% globally, and 30% in Europe. Lung fluid congestion leads to a vicious cycle of hospital readmissions of HF patients, with 1 in 4 patients readmitted to hospital within 30 days, and 1 in 2 patients readmitted within 6 months. The key challenge is to enable early detection and timely treatment of symptoms, before the patient undergoes respiratory distress (i.e. congestion in the lungs). CardioSet is introducing the Edema Guard Monitor (EGM), a non-invasive home monitoring system for lung congestion in heart failure (HF). EGM is the only non-invasive and easy to use home monitoring system which enables early and quick detection of lung fluid accumulation, days before visible clinical signs of lung congestion.